Pfizer intends to sell about 540 million shares in British consumer healthcare company Haleon, a bookrunner said on Monday, ...

This summary covers recent developments in health news, from Humana's slumping Medicare plan enrollments impacting future ...

Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6% ...

Health-care CVS Health has spent more than $88 billion in the last half-dozen years to add a major health insurer, a clinic operator and a home-visit provider to its namesake pharmacies, but the ...

The price of Brent crude jumped to above $75 a barrel having earlier in the day been below $70. Shell rose 2.2% and BP gained ...

Pharmaceutical giant Pfizer Inc. announced on Tuesday that it has reduced its stake in British consumer healthcare company ...

Oil prices jumped and stocks tumbled on Tuesday after Iran fired an estimated 180 missiles at Israel in retaliation for the ...

Separately, Haleon will also buy around £230 million worth of its shares from Pfizer at the price set in the share offering, ...

US pharmaceutical giant Pfizer concluded its second sell-down in its consumer healthcare spin-off, Haleon. It raised £2.432bn ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

The latest health news highlights include Kailera Therapeutics' $400 million funding, potential CVS Health restructuring, ...